PNC Financial Services Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Buy |
|
|||||
|
2025
Q1 | $855 | Buy |
|
|||||
|
2024
Q4 | $824 | Hold |
|
|||||
|
2024
Q3 | $2.6K | Hold |
|
|||||
|
2024
Q2 | $3.64K | Hold |
|
|||||
|
2024
Q1 | $6.25K | Sell |
|
|||||
|
2023
Q4 | $10.2K | Hold |
|
|||||
|
2023
Q3 | $7.78K | Hold |
|
|||||
|
2023
Q2 | $8.94K | Sell |
|
|||||
|
2023
Q1 | $16.8K | Hold |
|
|||||
|
2022
Q4 | $32K | Sell |
|
|||||
|
2022
Q3 | $36K | Sell |
|
|||||
|
2022
Q2 | $36K | Buy |
|
|||||
|
2022
Q1 | $74K | Hold |
|
|||||
|
2021
Q4 | $103K | Sell |
|
|||||
|
2021
Q3 | $176K | Hold |
|
|||||
|
2021
Q2 | $227K | Buy |
|
|||||
|
2021
Q1 | $222K | Sell |
|
|||||
|
2020
Q4 | $217K | Sell |
|
|||||
|
2020
Q3 | $400K | Buy |
|
|||||
|
2020
Q2 | $815K | Buy |
|
|||||
|
2020
Q1 | $73K | Buy |
|
|||||
|
2019
Q4 | $19K | Buy |
|
|||||
|
2019
Q3 | $10K | Hold |
|
|||||
|
2019
Q2 | $16K | Hold |
|
|||||
|
2019
Q1 | $20K | Hold |
|
|||||
|
2018
Q4 | $20K | Hold |
|
|||||
|
2018
Q3 | $28K | Hold |
|
|||||
|
2018
Q2 | $20K | Hold |
|
|||||
|
2018
Q1 | $24K | Hold |
|
|||||
|
2017
Q4 | $22K | Sell |
|
|||||
|
2017
Q3 | $154K | Buy |
|
|||||
|
2017
Q2 | $164K | Buy |
|
|||||
|
2017
Q1 | $133K | Sell |
|
|||||
|
2016
Q4 | $146K | Sell |
|
|||||
|
2016
Q3 | $317K | Sell |
|
|||||
|
2016
Q2 | $320K | Buy |
|
|||||
|
2016
Q1 | $210K | Buy |
|
|||||
|
2015
Q4 | $75K | Hold |
|
|||||
|
2015
Q3 | $64K | Hold |
|
|||||
|
2015
Q2 | $90K | Buy |
|
|||||
|
2015
Q1 | $82K | Sell |
|
|||||
|
2014
Q4 | $97K | Sell |
|
|||||
|
2014
Q3 | $108K | Buy |
|
|||||
|
2014
Q2 | $6K | Sell |
|
|||||
|
2014
Q1 | $26K | Hold |
|
|||||
|
2013
Q4 | $24K | Buy |
|
|||||
|
2013
Q3 | $10K | Buy |
|